Series - Raising Capital

With the majority of biological studies conducted in academic settings but nearly all innovative new drug clinical trials sponsored by industry, improving translational research success rates for commercialization is critical to bringing new treatments to patients. Surveys of academic tech transfer offices and the biopharma industry executives working on such alliances cite as obstacles two highly controllable factors: disagreement about alliance performance metrics and misalignment of deal terms priorities. This panel discusses best practices for removing such obstacles to accelerate more promising ideas into clinical development for patients.

BIO's updated 2023 report, "U.S. Biotechnology Translational Research: Partnership Models, Management Principles, and Best Practices," is available for download at the link below.  The webinar also summarizes major findings from that BIO report as context for the panel discussion and audience Q&A.

The BIO Investor Forum is back! Join us at the Hilton San Francisco Union Square from October 17-18 for two days of thought-leadership, partnering, and insight into investment trends and the priorities of venture-stage growth and emerging public biotech companies.

View this webinar to learn more about what’s happening this year, including a half-day pre-conference event, the BIO Seed-Stage Spotlight on Tech Transfer with 34 fast pitches from start-ups outlining their drug development programs.  This webinar will detail what the BIO One-on-One Partnering™ system can do for your business goals and how to use the system's powerful features.  Explore the program, networking opportunities, partnering system fundamentals, gain insight into best practices for partnering, and more.

For more information and to register for the BIO Investor Forum, please visit: https://www.bio.org/events/bio-investor-forum

Register now for the conference to get access to the partnering system and to request your meetings.

View this webinar to learn about the many exciting opportunities available at the 2023 BIO Asia-Taiwan International Conference & Exhibition. This webinar covers:

- Overview of the event schedule
- Preview of conference sessions and programming
- Live demo of the BIO One-on-One Partnering system, including new features such as Optional Meeting Participants, to enhance your business partnering experience
- Q&A with the speakers

Conference details at this link.

This webinar is for BIO 2023 attendees who are familiar with the BIO One-on-One Partnering™ system and want to use the platform more effectively. View this advanced partnering webinar—led by BIO’s Director of Partnering—to learn tips & tricks, commonly overlooked yet powerful features that will help you better identify companies of interest, and more. You can leverage these insights and features to take your partnering experience to the next level in Boston at this year's BIO International Convention.

Learn more and register for BIO 2023 at this link.

During this webinar, panelists discuss strategies for biotechnology companies to manage economic downturns and weakened investor interest in the biotech industry. Our expert panel of industry leaders share their insights and experiences on how to maintain momentum and emerge stronger during periods of economic uncertainty.

This webinar is designed to provide practical advice and actionable strategies that can be implemented immediately. The panel covers the following topics:

• Effective communication and investor relations strategies during economic downturns

• Actions biotechs can take to cut costs without sacrificing innovation and growth

• How to pitch to investors during weakened investor interest periods

Looking for an efficient and effective way to source new partnerships and manage your meetings for JPM Week 2023? View this webinar to learn more about how BIO One-on-One Partnering™ can help. Learn about BIO’s onsite meeting space in San Francisco, how to schedule your meetings with different location options, and a get a first look at the system’s newest feature – optional meeting participants. Also get a sneak peek at how you can stay in-the-know about networking and other opportunities during JPM week.

For more information and to register for BIO Partnering at JPM 2023, please visit: https://www.bio.org/events/bio-partnering-jpm/registration.

• Preview of BIO’s onsite meeting space in San Francisco 
• Partnering best practices & how to schedule your meetings
• Live demo of the system’s latest feature – optional meeting participants
• Sneak peak of BIO and Novateur Ventures’ JPM Week Events Guide mobile app
• Q&A with the host

• Opening Remarks: Overview and Department of Defense Priorities
• Investing at the Speed of Need: Novel Technologies and Platforms to Accelerate Drug Development

The US Government invests in biomedical research in many ways, including direct funding of some critical R&D areas for diagnostics, vaccines, and therapeutics that could strengthen biodefense preparedness. This BIO-hosted webinar details for the biotechnology corporate and academic community the many new and previously available sources of capital, as well as the processes for applying for funding, from the US Department of Defense.

The Department of Defense (DoD) is continuously engaging in efforts to protect the warfighter from a broad array of threats. Preparing for and responding to these threats requires key partnerships with the industry to develop vaccines, therapeutics, and diagnostics that are designed specifically to meet the unique needs of the warfighter in various situations. Many of the investments made through these partnerships also support broader applications of key biotechnologies for other unmet healthcare needs. This important webinar represents an opportunity for BIO members and the whole biotechnology community to get an update about the priorities and programs within the DoD and the ways companies can work with the Agency on their priorities.

• Repurposing and Redirecting: An Alternate Approach to Accelerating Medical Countermeasures

The US Government invests in biomedical research in many ways, including direct funding of some critical R&D areas for diagnostics, vaccines, and therapeutics that could strengthen biodefense preparedness. This BIO-hosted webinar details for the biotechnology corporate and academic community the many new and previously available sources of capital, as well as the processes for applying for funding, from the US Department of Defense.

The Department of Defense (DoD) is continuously engaging in efforts to protect the warfighter from a broad array of threats. Preparing for and responding to these threats requires key partnerships with the industry to develop vaccines, therapeutics, and diagnostics that are designed specifically to meet the unique needs of the warfighter in various situations. Many of the investments made through these partnerships also support broader applications of key biotechnologies for other unmet healthcare needs. This important webinar represents an opportunity for BIO members and the whole biotechnology community to get an update about the priorities and programs within the DoD and the ways companies can work with the Agency on their priorities.

How to Work with the Department of Defense

The US Government invests in biomedical research in many ways, including direct funding of some critical R&D areas for diagnostics, vaccines, and therapeutics that could strengthen biodefense preparedness. This BIO-hosted webinar details for the biotechnology corporate and academic community the many new and previously available sources of capital, as well as the processes for applying for funding, from the US Department of Defense.

The Department of Defense (DoD) is continuously engaging in efforts to protect the warfighter from a broad array of threats. Preparing for and responding to these threats requires key partnerships with the industry to develop vaccines, therapeutics, and diagnostics that are designed specifically to meet the unique needs of the warfighter in various situations. Many of the investments made through these partnerships also support broader applications of key biotechnologies for other unmet healthcare needs. This important webinar represents an opportunity for BIO members and the whole biotechnology community to get an update about the priorities and programs within the DoD and the ways companies can work with the Agency on their priorities.